ACHE and Alzheimer disease: Cells treated with the acetylcholinesterase inhibitor donepezil, used clinically in the treatment of AD, also showed reduced glutamate NMDAR mediated Ca2+ influx, an effect which was blocked by an α7nAChR antagonist [100].